Gamida Cell Ltd. PT Lowered to 6 at JMP Securities

GMDADelisted Stock  USD 1.40  0.09  6.04%   
About 61% of Gamida Cell's investor base is looking to short. The analysis of current outlook of investing in Gamida Cell suggests that many traders are alarmed regarding Gamida Cell's prospects. The current market sentiment, together with Gamida Cell's historical and current headlines, can help investors time the market. In addition, many technical investors use Gamida Cell stock news signals to limit their universe of possible portfolio assets.
  
JMP Securities analyst Jason N. Butler lowered the price target on Gamida Cell Ltd. to 6.00 while maintaining a Market Outperform rating.

Read at streetinsider.com
Street Insider News
  

Gamida Cell Fundamental Analysis

We analyze Gamida Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gamida Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gamida Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Gamida Cell is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Gamida Cell Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gamida Cell stock to make a market-neutral strategy. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics with similar companies.

Peers

Gamida Cell Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
TERNTerns Pharmaceuticals   7.82   
0%
68.0%
HOOKHookipa Pharma   6.90   
0%
60.0%
ARDXArdelyx   6.36   
0%
55.0%
MCRBSeres Therapeutics   4.55   
0%
39.0%
BLRXBioLineRx   3.57   
0%
31.0%
IOVAIovance Biotherapeutics   3.07   
0%
26.0%
INZYInozyme Pharma   2.64   
0%
23.0%
DAWNDay One   1.33   
0%
11.0%
PLXProtalix Biotherapeutics   0.60   
0%
5.0%
IBRXImmunitybio   0.39   
3.0%
0%
LXRXLexicon Pharmaceuticals   2.44   
21.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Gamida Stock

If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamental Analysis
View fundamental data based on most recent published financial statements